Creso Pharma (ASX:CPH) share price lifts following two positive updates

It's been a tough year for shareholders of this cannabis product developer but there's good news today.

| More on:
cannabis farmer in the fields checking the crops

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price edged higher during morning trade after the company announced the launch of new e-commerce channels and its first purchase order from Poland.

The Creso share price rose by more than 8% above yesterday's close to 13 cents, before settling back to 12 cents in mid-afternoon trade.

Creso expands market presence

According to the release, Creso advised it has increased its European market presence with the launch of an e-commerce channel and marketing campaign. The online platform will sell a range of new human health products designed for sport, health and wellness.

This marks the first time Creso has utilised an e-commerce platform to unlock a new potential revenue stream.

The platform underwent a special development process with input from potential customers, suppliers and consumers. It will initially target Swiss customers and then expand throughout Europe.

Switzerland represents a large addressable market of CHF 21 billion (A$31 billion) for sports-related activities.

Creso will undertake an active marketing campaign using direct mailouts and social media targeting consumers.

The company also announced that it has received its first purchase order from Poland. The company that placed the order is the Polish medical and pharmaceutical company, Polvet.

The order consists of Creso hemp flour-based, anibidiol granule product for pets, large companion animals and livestock. Valued at roughly $80,000, the products will be used in Polvet's animal clinics and distributed through established channels.

Creso head of international operations Jorge Wernli commented:

Creso Pharma's European operations continue to grow … This represents a key strategic milestone in broadening our global footprint, as well as our presence in sports and recreational markets.

We will continue to pursue growth opportunities across Europe and can now focus on both business to business and direct to consumer paths. The Company will continue to update shareholders on progress in the coming months.

About the Creso share price

This year has been challenging for Creso shareholders. The Creso share price has fallen 33% year to date and 7.7% over the past month.

Creso has a market capitalisation of approximately $144.2 million with 1.2 billion shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Man holding Australian dollar notes, symbolising dividends.
Dividend Investing

Want to build up passive income? These 2 ASX dividend shares are a buy!

These stocks are giving investors exciting payouts every year.

Read more »

Man on a ladder drawing an increasing line on a chalk board symbolising a rising share price.
Growth Shares

2 ASX shares to buy and hold for the next decade

These businesses have a lot of growth potential ahead…

Read more »

Three satisfied miners with their arms crossed looking at the camera proudly
Materials Shares

ASX 200 materials sector outperforms as mining shares continue their ascent

Plenty of ASX 200 mining shares hit multi-year highs last week amid continually rising commodity values.

Read more »

A group of people push and shove through the doors of a store, trying to beat the crowd.
Broker Notes

2 ASX shares highly recommended to buy: Experts

Are these two stocks the best buys on the ASX?

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Broker Notes

These ASX 200 shares could rise 20% to 55%

Brokers have good things to say about these shares.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

I'd buy 5,883 shares of this ASX stock to aim for $1,000 of annual passive income

I’d pick this stock for its strong dividend record.

Read more »

A player pounces on the ball in the scoring zone of the field.
Best Shares

4 ASX 300 shares that ripped 100% or more in 2025

The S&P/ASX 300 Index rose 7.17% and delivered a total return, including dividends, of 10.66% in 2025.

Read more »

A little girl is about to launch down the slide with a blue sky and white clouds in the sky behind her.
Broker Notes

BHP vs. Fortescue shares: Goldman Sachs says 1 will rip and 1 will dip

Top broker Goldman Sachs upgraded its 12-month share price forecasts for BHP and Fortescue shares this week.

Read more »